Aneon Federal and Brillient JV wins FDA Oncology Center of Excellence Benefits Risk Professional Services contract

Yet another key win in support of the Food and Drug Administration (FDA) for this SBA-approved 8(a) joint venture that includes Brillient, an award-winning Full Spectrum Digital Transformation company and 2025 Elev8 GovCon honoree who is enabling clients to transform through the continuum of analog, to digital, to analytics, leading to insight-driven decision making and mission execution.

Awardee Name: ANEON BRILLIENT, LLC
Unique Entity ID: MS8HMAY331Q5
Total Contract Value: $2,220,109.12
Action Obligation: $2,220,109.12
Department Name: HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Funding Agency: FOOD AND DRUG ADMINISTRATION
Number of Bidders: 1
Award ID: 75F40125C00027
RFP ID: 75F40125R00064
Set Aside Used: 8(a) Sole Source
NAICS: 541611
Award Type: Definitive Contract
Start Date: 2025-06-04
Ultimate Completion Date: 2026-08-11




Not Yet a Premium Partner/Sponsor? Learn more about the OS AI Premium Corporate and Individual Plans here. Plans start at $295 annually.

LEAVE A REPLY

Please enter your comment!
Please enter your name here